The Alberta Innovates Centre for Carbohydrate Science began operation
In Sept. 2002, the Alberta Innovates Centre for Carbohydrate Science (now Alberta Glycomics Centre), began operation with a…
-
-
Biotechnology | Chemistry | FDA | Oncology | Radiology | Therapeutics
FDA approved Amgen’s aranesp for anemia associated with chemotherapy
On Jul. 22, 2002, Amgen announced that the U.S. Food and Drug Administration (FDA) had approved Aranesp (darbepoetin…
-
NCI funded trial showed postmenopausal women who used estrogen replacement therapy were at higher risk of developing ovarian cancer
On Jul. 17, 2002, a National Cancer Institute funded trial showed that postmenopausal women who used estrogen replacement…
-
Immunex Corp. was acquired by Amgen for $16 billion
On Jul. 16, 2002, Amgen completed it’s acquisition of Immunex Corporation for $16 billion in stock and net…
-
Biotechnology | CDC | Diagnostics | HIV | Therapeutics | Women's Health
The CDC reported newborn HIV infection reductions of 80% since 1981
On Jul. 9, 2002, the U.S. Centers for Disease Control and Prevention (CDC) reported newborn HIV infection reductions…
-
The UC Davis Cancer Center received NCI designation
On Jul. 2, 2002, the University of California, Davis Comprehensive Cancer Center announced it had received National Cancer…
-
University of Minnesota researchers Povide Evidence That Adults Stem Cells Differentiate Like Embryonic Stem Cells
On Jun. 24, 2002, researchers at the University of Minnesota Stem Cell Institute (SCI) announced they had found…
-
Biotechnology | Chemistry | Diagnostics | NIH | Oncology | Therapeutics
NCI scientists identified adult patients with non-Hodgkin’s lymphoma likely to be cured by chemotherapy
On Jun. 19, 2002, National Cancer Institute (NCI) scientists used microarray technology to determine the patterns of genes…
-
Biotechnology | CDC | Diagnostics | FDA | Infectious Disease | Medicine | NIH | Plague | Radiology | Therapeutics | U.S. Congress
President Bush signed the Public Health Security and Bioterrorism Preparedness and Response Act into law
On Jun. 12, 2002, President George W. Bush signed the Public Health Security and Bioterrorism Preparedness and Response…
-
The Public Health Security and Bioterrorism Preparedness and Response Act (PL 107-188) was signed
On Jun. 12, 2002, the Public Health Security and Bioterrorism Preparedness and Response Act (P.L. 107-188) was passed…
-
The Salt River Pima-Maricopa Indian Community pledged $5 million to the Translational Genomics Research Institute
On Jun. 8, 2002, the Salt River Pima-Maricopa Indian Community pledged $5 million to the Translational Genomics Research…
-
The Translational Genomics Research Institute (TGen) was founded
In Jun. 2002, the Translational Genomics Research Institute (TGen), a non-profit 501(c)(3) organization focused on developing earlier diagnostics…
-
NCI researchers reported that the molecularly targeted drug bevacizumab slowed tumor growth in patients with metastatic renal cell carcinoma
On May 19, 2002, researchers from the National Cancer Institute reported that the molecularly targeted drug bevacizumab slowed…
-
The International Genomics Consortium selected Phoenix for its headquarters
On May 14, 2002, the International Genomics Consortium (IGC) selected Phoenix for its headquarters. The mission of the…
-
Biotechnology | CDC | NIH | Oncology | Therapeutics | U.S. Congress
The Hematologic Cancer Research Investment and Education Act Signed into Law
On May 14, 2002, President George W. Bush signed the Hematologic Cancer Research Investment and Education Act of…
-
Governor Hull signed SB 1270 that provided $5 million over 10 years for genomic research
In May 2002, Governor Hull signed SB 1270 for $5 million over 10 years for genomic research. Later…
-
BOTOX(R) cosmetic (onabotulinumtoxinA) approved by the FDA
On Apr. 15, 2002, BOTOX(R) cosmetic (onabotulinumtoxinA), manufactured by Allergan, was approved by the Food and Drug Administration…
-
GlaxoSmithKline announced the company would no longer manufacture or distribute its Lyme disease vaccine
On Feb. 25, 2002, GlaxoSmithKline announced that the company would no longer manufacture or distribute its Lyme disease…
-
Pioneer Hi-Bred International endowed Maize Breeding Chair at Iowa State University
On Feb. 12, 2002, Pioneer Hi-Bred International made a gift to endow a faculty chair in maize breeding…
-
Scientists from NCI and FDA reported that patterns of proteins found in patients’ serum may reflect the presence of ovarian cancer
On Feb. 7, 2002, scientists from the National Cancer Institute (NCI) and the Food and Drug Administration (FDA)…
-
The Translational Genomics Research Institute (TGen) was envisioned
On Feb. 7, 2002, an assembly of more than fifty leaders and visionaries in science, medicine, government and…
-
FDA approved Gleevec for gastrointestinal stromal tumors treatment
On Feb. 1, 2002, the U.S. Food and Drug Administration (FDA) approved the drug Gleevec, formerly known as…
-
ZymoGenetics announced its Initial Public Offering
On Jan. 10, 2002, ZymoGenetics, a former Novo Nordisk subsidiary, announced its IPO at $12.00 per share with…
-
Digital diagnostic technology developed with creation of AQUA (Automated Quantitative Analysis) at Yale Cancer Center
In 2002, digital diagnostic technology was developed with the creation of AQUA (Automated Quantitative Analysis) at Yale Cancer…
-
Red River Valley Research Corridor was established
In 2002, The Red River Valley Research Corridor was established by U.S. Senator Byron Dorgan. The corridor is…
-
The Nevada Cancer Institute was founded
In 2002, the Nevada Cancer Institute (NVCI), founded in 2002 and located in Summerlin, was a non-profit organization…
-
Biotechnology | Diagnostics | Disease | Medicine | Oncology | Therapeutics
The Cancer Center at Baylor College of Medicine was established
In 2002, the Cancer Center at Baylor College of Medicine, now known as the Dan L Duncan Comprehensive…
-
ViaGen was founded in Austin, Texas
In 2002, ViaGen was founded in Austin, Texas in to provide commercial bovine, equine, and porcine gene banking,…
-
Gateway Building opened at Virginia Commonwealth University Medical Center
In 2002, The Gateway Building opened at VCU Medical Center, a $39 million dollar structure, opened in March…
-
Pacific Northwest Research Institute led consortium that conducted first human islet transplantation in Puget Sound region
On Jul. 30, 2002, clinical researchers announced they had teamed together to perform the first human islet transplants…
